Enhanced cortical-limbic interaction

“Emotional regulation via enhanced cortical-limbic interaction” does **not** refer to a single molecule, receptor, enzyme, or other canonical therapeutic target. Instead, it describes the **functional interplay between the cerebral cortex—especially the prefrontal cortex—and limbic system structures such as the amygdala, hippocampus, hypothalamus, and cingulate gyrus**. This network is essential for processing emotions, regulating their intensity and duration, integrating emotional experiences with cognition and memory formation[1][2]. The prefrontal cortex exerts top-down control over limbic responses—modulating emotional reactivity generated by subcortical structures like the amygdala[1]. Dysfunction in this circuitry is implicated in numerous neuropsychiatric conditions including depression, anxiety disorders, PTSD, bipolar disorder,[1][2][3] but there is no single druggable entity corresponding to this concept. In summary: This entry does not correspond to an individual molecular or pharmacological target but rather describes a complex neural circuit involved in emotion regulation. It should not be treated as a canonical drug discovery or biomarker entry.

Other names

Enhanced cortical-limbic interactionEmotional regulation via limbic systemCortical-limbic emotional regulation